Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2007 Vol. 2
p
 
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2007 Vol. 2
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 3: Diagnostics & Assays
 

Devices for Nanoparticle-based Cancer Detection

Authors:G.Y. Kim, K.D. Daniel, C.C. Vassiliou, N. Elman, L. Josephson and M.J. Cima
Affilation:MIT, US
Pages:218 - 220
Keywords:nanoparticle, biomarker, sensor, implantable, bHCG
Abstract:This implantable biomarker sensor combines nanoscale magnetic relaxation switches (MRSW) and the versatility of microfabricated structures tp be read by MRI. MRSW are magnetic iron oxide nanoparticles that can be functionalized to detect a variety of analytes (Perez, Nature Biotech 2002). The presence of analyte causes the MRSW to aggregate, causing a change in T2. The MRSW are packaged into a device to expose the MRSW to the tumor milieu. MRSW were functionalized to detect the beta subunit of human chorionic gonadotrophin (betaHCG), which is elevated in testicular and ovarian cancers. The addition of betaHCG to the MRSW resulted in T2 shortening as seen in test-tubes and in prototype devices by NMR spectroscopy and MRI respectively. This biomarker sensor will be tested in cell lines producing betaHCG and in nude mice bearing ectopic tumors. To our knowledge, this is the first nanoparticle system to detect betaHCG biomarker via T2 shortening. This is also the first demonstration of T2 shortening response inside a semi-permeable device. This method can be adapted to detect other circulating biomarkers.
ISBN:1-4200-6183-6
Pages:838
Hardcopy:$199.99
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact